Immunotherapy toxicity survey

UCLH cancer academy has been funded to develop multidisciplinary education on check point inhibitors and immune related adverse events.  We are very keen that the materials we produced are helpful to the whole BOPA membership.  To understand where the gaps are we have developed a questionnaire (see link below).  It will take less than 10 minutes to complete and will be really helpful for us to understand where the gaps are at different hospitals.  Please could this be completed by June 2nd.  If you have any questions or would like to keep in touch with our work, then please email Elly on [email protected].

https://forms.office.com/e/rAAj4DzjNK

Latest News

By BOPA Executive Committee on 15th July 2025

BSH Membership Survey 2025 – Pharmacy input required!

BOPA Members, As part of our ongoing  and increased collaborations with the British Society of Haematology (BSH) we would like to circulate the BSH Membership Survey 2025.  BSH are seeking…

Read article
By BOPA Immunotherapy Specialist Advisory Group on 14th July 2025

IOCN and UKSACT Board joint letter to NHSE

Hello All One of the pressing issues the BOPA Immunotherapy Specialist Advisory Group has been working over the past year, is addressing/improving the access to second line immunosuppressants for the…

Read article
By BOPA Committee on 14th July 2025

2025 Elections to the BOPA Executive Committee: Call for nomination of members

BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those…

Read article
By BOPA committee on 10th July 2025

Update to BOPA Standards – New Guidance on Pharmacy Technician SACT Verification (Section 3.3)

Dear BOPA Members, We are pleased to share an important update to the BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines (Version 5.0, 3 June 2025). A…

Read article